Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Krakow
Clinical trial register · Poland

Clinical Trials in Krakow, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 61 Krakow 42 Bydgoszcz 37 Lublin 30 Gda?sk 28
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca70 Hoffmann-La Roche42 Eli Lilly and Company38 Merck Sharp & Dohme LLC36 Janssen Research & Development, LLC36 Clear sponsor filter
Site location
Warsaw61 Krakow42 Bydgoszcz37 Lublin30 Gda?sk28
All 79 locations
Target enrolment
to

Trials with a site in Krakow

42 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Hoffmann-La Roche
Phase 3
380
Krakow, Gda?sk, Późna, Szczecin, Warsaw, Wroc?aw
2026-06-23
Recruiting
Hoffmann-La Roche
Phase 2/3
650
?ód?, Katowice, Krakow, Olsztyn, Opole, Późna, Tomaszów Mazowiecki, Wroc?aw
2026-05-21
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Bialystok, Bydgoszcz, Gdynia, Krakow, Lublin, Opole, Tarnów, Tychy
2026-03-16
Active, closed
Hoffmann-La Roche
Phase 2
120
Katowice, Gdynia, Krakow, Rzeszów, Warsaw
2026-01-08
Recruiting
Hoffmann-La Roche
Phase 2
160
Bytom, Elbl?g, Krakow, Lublin, Nowa Sól, Warsaw, Wroclaw
2025-12-05
Recruiting
Hoffmann-La Roche
Phase 3
250
Krakow, Bielsko-Biala, Bydgoszcz, Gliwice, Lódz, Lublin, Olsztyn
2025-11-27
Recruiting
Hoffmann-La Roche
Phase 3
900
Bia?ystok, Bydgoszcz, Gda?sk, Katowice, Krakow, Lublin, Oświęcim, Rzeszów
2025-11-24
Active, closed
Hoffmann-La Roche
Phase 3
1,060
?cinawa, ?ory, ?ód?, B?dzin, Bia?ystok, Gdansk, Krakow, Późna
2025-11-12
Recruiting
Hoffmann-La Roche
Phase 3
600
Bystra, Gda?sk, Krakow, Lublin, Olsztyn, Poznan, Radom, Warsaw
2025-10-24
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Bydgoszcz, Katowice, Krakow, Lublin, Rzeszów, Warsaw, Wroc?aw, Zabrze
2025-09-17
Recruiting
Hoffmann-La Roche
Observational
700
Krakow, Lublin, Olsztyn, Poznan, Słupsk, Tomaszów Mazowiecki
2025-07-15
Recruiting
Hoffmann-La Roche
Phase 3
425
Bia?ystok, Bydgoszcz, Elblag, I?awa, Knurów, Krakow, Lodz, Lublin
2025-05-12
Active, closed
Hoffmann-La Roche
Phase 2
285
Krakow, Gdansk, Lublin, Warsaw
2025-05-05
Recruiting
Hoffmann-La Roche
Not applicable
270
Gdansk, Krakow, Kraśnik, Lublin, Nadarzyn, Warsaw
2025-04-14
Recruiting
Hoffmann-La Roche
Phase 3
450
?ód?, Bialystok, Konin, Koszalin, Krakow, Lublin, Późna, Rzeszów
2025-04-09
Active, closed
Hoffmann-La Roche
Phase 2
162
Gdynia, Katowice, Krakow, Rzeszów, Warsaw
2025-04-01
Recruiting
Hoffmann-La Roche
Phase 3
600
??czna, ?ód?, Bia?ystok, Bydgoszcz, Chojnice, Karczew, Krakow, Nowy Targ
2025-03-17
Active, closed
Hoffmann-La Roche
Phase 3
350
?ód?, Bydgoszcz, Elblag, I?awa, Knurów, Krakow, Lublin, Poznan
2024-12-11
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,800
Katowice, Krakow, Lodz, Mysłowice, Warsaw, Wroclaw
2024-05-24
Active, closed
Hoffmann-La Roche
Phase 2
256
?ory, Bia?ystok, Bydgoszcz, Katowice, Krakow, Sopot, Szczecin, Warsaw
2024-05-02
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,350
Katowice, Krakow, Lodz, Mysłowice, Warsaw, Wroclaw
2024-03-13
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Brzozów, Gda?sk, Katowice, Kielce, Krakow, Wroc?aw
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
459
Wroclaw, Krakow, Lodz, Opole, Poznan, Warsaw
2023-08-08
Active, closed
Hoffmann-La Roche
Phase 2
83
Kielce, Krakow
2023-07-18
Recruiting
Hoffmann-La Roche
Phase 1/2
320
Gda?sk, Krakow, Olsztyn
2023-06-20
Recruiting
Hoffmann-La Roche
Phase 3
420
Bydgoszcz, Gdynia, Gliwice, Konin, Koszalin, Krakow, Rzeszów, Warsaw
2023-06-07
Active, closed
Hoffmann-La Roche
Phase 2
199
Brzozów, Bydgoszcz, Krakow, Późna
2023-04-21
Active, closed
Hoffmann-La Roche
Phase 2
204
Koszalin, Krakow, Późna, Warsaw
2023-04-13
Active, closed
Hoffmann-La Roche
Phase 2
301
Gdansk, Krakow, Warsaw
2023-02-03
Active, closed
Hoffmann-La Roche
Phase 3
122
Krakow, Zabrze
2022-09-27
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Bydgoszcz, Gda?sk, Katowice, Krakow, Lodz, Lublin, Olsztyn, Plewiska
2022-05-03
Recruiting
Hoffmann-La Roche
Phase 1
332
Gda?sk, Krakow, Wroc?aw
2022-03-07
Active, closed
Hoffmann-La Roche
Phase 3
660
Gda?sk, Krakow, Olsztyn, Otwock, Poznan, Warsaw
2021-11-18
Recruiting
Hoffmann-La Roche
Phase 1
542
Gdansk, Krakow, Poznan, Warsaw
2021-10-22
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Bydgoszcz, Gdynia, Gliwice, Grudziądz, Krakow, Lodz, Lublin, Poznan
2021-08-27
Active, closed
Hoffmann-La Roche
Phase 2
586
?ód?, Bydgoszcz, Gda?sk, Krakow, Lublin, Rzeszów, Warsaw
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Bialystok, Gda?sk, Gliwice, Krakow, Poznan, Warsaw
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Krakow, Poznan, Warsaw, Wroclaw
2021-05-03
Active, closed
Hoffmann-La Roche
Phase 3
751
Bydgoszcz, Gdansk, Kielce, Krakow, Lodz, Oświęcim, Plewiska, Poznan
2021-03-24
Active, closed
Hoffmann-La Roche
Phase 3
769
Bydgoszcz, Gdansk, Katowice, Krakow, Lodz, Lublin, Oświęcim, Plewiska
2020-12-03
Active, closed
Hoffmann-La Roche
Phase 3
257
Gda?sk, Krakow, Olsztyn, Poznan
2018-08-16
Active, closed
Hoffmann-La Roche
Phase 3
927
Bialystok, Krakow, Lodz, Późna, Rzeszów, Warsaw, Zabrze
2018-05-28
Rows per page Showing 1–42 of 42
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-poland/city/krakow

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 42 of those studies with a site in Krakow that also match the filters currently applied.

How many clinical trials are recruiting in Krakow?

18 of the 42 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 24 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Krakow), 42 studies
PhaseStudiesRecruitingShare
Phase 3261161.9%
Phase 210123.8%
Phase 1224.8%
Not applicable112.4%
Observational112.4%
Phase 1/2112.4%
Phase 2/3112.4%

Most active sponsors

Lead sponsors with the most studies (Krakow)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche4218
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.